Rubber-stamping risky new diabetes drugs at a record pace seems to be the latest mainstream trend. Recently, Trulicity, a once-a-week injection from Eli Lilly and Co, was fast-tracked onto both the American and European markets, despite serious concerns over its safety.
With diabetes rates skyrocketing and fierce competition among those in the drug industry, pharmaceutical companies are hatching plans to combine some of their most dangerous diabetes drugs… medications that have been linked to heart disease and even cancer… into new, dangerous formulations they hope will rake in billions.
It’s all about the money
Glyxambi (manufactured by Eli Lilly and Boehringer Ingelheim) has recently been approved by the American Food and Drug Administration (FDA) and the first thing you should know about this drug is that it is not the brand-spanking-new breakthrough drug it is made out to be. In fact, it’s a combination of two very risky diabetes drugs.
The first half of this horror was approved last summer under the brand name Jardiance — known as a SGLT2 inhibitor that forces your kidneys to excrete glucose in your urine.
While peeing your diabetes away may sound like a good idea, once you realise that Jardiance can trigger a deadly drop in blood pressure that can cause everything from dizziness to dangerous falls, you’ll want to steer clear of this drug at all costs.
SGLT2 inhibitors like Jardiance have also been linked to what experts call “a cascade of adverse events,” including urinary tract infections and serious kidney and heart problems.
And here’s the worst part — Jardiance is not the most dangerous drug in the Glyxambi-combination.
The second half of this two-drug cocktail is called Tradjenta, which mimics a natural hormone in your body called GLP-1 that controls blood sugar.
It also sends your risk of pancreatic and thyroid cancer through the roof.
The Institute for Safe Medicine Practices found that compared to older type 2 diabetes treatments, such as metformin, your risk of pancreatitis and pancreatic cancer is 25 times higher on these GLP-1 medications like Tradjenta.
But it’s not like the makers of Glyxambi are even trying to hide these hideous side effects, because the warning label on Glyxambi clearly says it increases your risk of “pancreatitis which may be severe and lead to death.” Pancreatitis, a severe swelling of your pancreas, is also a major risk factor for pancreatic cancer.
So if your doctor mentions some new way to treat your type 2 diabetes, remember, Glyxambi is a potentially deadly cocktail of two very dangerous diabetes drugs in one.
The only “new” thing about Glyxambi is its name. That, and the double dose of danger you get from it.
Wishing you the best of health,
Real Diabetes Truth
|Sign up to receive the Real Diabetes Truth e-letter today and get instant access to our FREE report, 10 Diet Secrets for Healthy Blood Sugar.|
Bear in mind we are not addressing anyone’s personal situation and you should rely on this for informational purposes only. Please consult with your own physician before acting on any recommendations contained herein.
“US launch for BI/Lilly diabetes combo Glyxambi” Selina McKee, March 23, 2015, PharmaTimes, pharmatimes.com
Category: Diabetes Drugs